News Posts List
Sixth annual 'Lift For Life' set for July 11
06/20/2008
University Park, Pa. During its first five years, Penn State Football Uplifting Athletes' "Lift For Life®" has experienced tremendous growth. More than $230,000 has been raised for the Kidney Cancer Association and members of 2008 Nittany Lion squad are looking to continue the growing contributions to this great cause. The Sixth Annual Penn State "Lift For Life" is set for Friday, July 11 from 2-7 p.m. in Holuba Hall. Last year's "Lift For Life" was the most successful to date, with more than 90 Nittany Lion football student-athletes testing their strength and endurance in an 11-event strength and conditioning challenge that raised more than $80,000 for the Kidney Cancer Association.
Toby Keith fundraiser brings in $709000
06/19/2008
The money goes to Ally's House, a charity started after original band member Scott Webb's 2-year-old daughter, Allison, died of kidney cancer in 2003.
A free archive of life sciences journals
06/19/2008
PubMed Central (PMC) is the U.S. National Institutes of Health (NIH) free digital archive of biomedical and life sciences journal literature.
Support kidney cancer research and education
06/19/2008
100% of the net proceeds from the sale of the new, official, Kidney Cancer T-shirt support research and education.
Weight-loss surgery slashes cancer risk
06/19/2008
Morbidly obese patients who undergo weight-loss surgery greatly reduce their risk of cancer, according to a study providing fresh evidence of health benefits from these increasingly common operations.
Studies Explore the Many Complex Linkages Between Smoking and Cancer (AACR)
06/18/2008
It's not as simple as you may think.
News about the latest kidney cancer research from the experts at ASCO
06/17/2008
Extensive FREE information from the American Society of Clinical Oncology website.
You Can Survive Cancer (I Did)
06/15/2008
I hope you can learn from my experience without having to go through a health crisis of your own.
Axitinib (Ag 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
06/15/2008
News of a Pfizer sponsored clinical trial.
Clinical trial results for new drug axitinib
06/14/2008
Axitinib (AG-013736) is an oral, potent, and selective inhibitor of vascular endothelial growth factor receptors 1, 2, and 3. We aimed to assess the activity and safety of axitinib in patients with metastatic renal-cell cancer who had failed on previous cytokine-based treatment.
News Feed